TMPO-AS1 Regulates the Aggressiveness-Associated Traits of Nasopharyngeal Carcinoma Cells Through Sponging miR-320a

References

• Huang Q, Hou S, Zhu X, Liu S. MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway. World J Surg Oncol. 2020;18(1):29. doi:10.1186/s12957-020-1798-y32013999
   PubMed Web of Science ®Google Scholar
• Duan B, Shi S, Yue H, et al. Exosomal miR-17-5p promotes angiogenesis in nasopharyngeal carcinoma via targeting BAMBI. J Cancer. 2019;10(26):6681–6692. doi:10.7150/jca.3075731777597
   PubMed Web of Science ®Google Scholar
• Wu S, Xie DL, Dai XY. Down-regulation of miR-155 promotes apoptosis of nasopharyngeal carcinoma CNE-1 cells by targeting PI3K/AKT-FOXO3a signaling. Eur Rev Med Pharmacol Sci. 2019;23(17):7391–7398. doi:10.26355/eurrev_201909_1884731539126
   PubMed Web of Science ®Google Scholar
• Ji L, Fan X, Zhou F, et al. lncRNA RPL34-AS1 inhibits cell proliferation and invasion while promoting apoptosis by competitively binding miR-3663-3p/RGS4 in papillary thyroid cancer. J Cell Physiol. 2020;235(4):3669–3678. doi:10.1002/jcp.2925631587286
   PubMed Web of Science ®Google Scholar
• Wang Y, Bhandari A, Niu J, et al. The lncRNA UNC5B-AS1 promotes proliferation, migration, and invasion in papillary thyroid cancer cell lines. Hum Cell. 2019;32(3):334–342. doi:10.1007/s13577-019-00242-830805847
   PubMed Web of Science ®Google Scholar
• Jia Y, Duan Y, Liu T, et al. LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging miR-142-5p to regulate CDK5. Cell Death Dis. 2019;10(8):573. doi:10.1038/s41419-019-1811-y31363080
   PubMed Web of Science ®Google Scholar
• Yang J, Liang B, Hou S. TMPO-AS1 promotes cervical cancer progression by upregulating RAB14 via sponging miR-577. J Gene Med. 2019;21(11):e3125. doi:10.1002/jgm.312531483914
   PubMed Web of Science ®Google Scholar
• Gang X, Yuan M, Zhang J. Long non-coding RNA TMPO-AS1 promotes cervical cancer cell proliferation, migration, and invasion by regulating miR-143-3p/ZEB1 axis. Cancer Manag Res. 2020;12:1587–1599. doi:10.2147/CMAR.S22640932184662
   PubMed Web of Science ®Google Scholar
• Guo X, Wang Y. LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway. Cancer Med. 2020;9(14):5235–5246. doi:10.1002/cam4.304632462698
   PubMed Web of Science ®Google Scholar
• Zheng Z, Li X, You H, et al. LncRNA SOCS2-AS1 inhibits progression and metastasis of colorectal cancer through stabilizing SOCS2 and sponging miR-1264. Aging (Albany NY). 2020;12(11):10517–10526. doi:10.18632/aging.10327632437330
   PubMedGoogle Scholar
• Cui H, Zhao J. LncRNA TMPO-AS1 serves as a ceRNA to promote osteosarcoma tumorigenesis by regulating miR-199a-5p/WNT7B axis. J Cell Biochem. 2020;121(3):2284–2293. doi:10.1002/jcb.2945131680323
   PubMed Web of Science ®Google Scholar
• Sun S, Hang T, Zhang B, et al. miRNA-708 functions as a tumor suppressor in colorectal cancer by targeting ZEB1 through Akt/mTOR signaling pathway. Am J Transl Res. 2019;11(9):5338–5356.31632515
   PubMed Web of Science ®Google Scholar
• Li Z, Rana TM. Therapeutic targeting of microRNAs: current status and future challenges. Nat Rev Drug Discov. 2014;13(8):622–638. doi:10.1038/nrd435925011539
   PubMed Web of Science ®Google Scholar
• van Rooij E, Olson EN. MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nat Rev Drug Discov. 2012;11(11):860–872. doi:10.1038/nrd386423080337
   PubMed Web of Science ®Google Scholar
• Li Y, Liu H, Shao J, Xing G. miR-320a serves as a negative regulator in the progression of gastric cancer by targeting RAB14. Mol Med Rep. 2017;16(3):2652–2658. doi:10.3892/mmr.2017.693728713899
   PubMed Web of Science ®Google Scholar
• Zhao W, Sun Q, Yu Z, et al. MiR-320a-3p/ELF3 axis regulates cell metastasis and invasion in non-small cell lung cancer via PI3K/Akt pathway. Gene. 2018;670:31–37. doi:10.1016/j.gene.2018.05.10029803922
   PubMed Web of Science ®Google Scholar
• Lee HM, Okuda KS, Gonzalez FE, Patel V. Current perspectives on nasopharyngeal carcinoma. Adv Exp Med Biol. 2019;1164:11–34.31576537
   PubMed Web of Science ®Google Scholar
• Lee AWM, Ng WT, Chan JYW, et al. Management of locally recurrent nasopharyngeal carcinoma. Cancer Treat Rev. 2019;79:101890. doi:10.1016/j.ctrv.2019.10189031470314
   PubMed Web of Science ®Google Scholar
• Zhou DN, Ye CS, Yang QQ, Deng YF. Integrated analysis of transcriptome profiling predicts potential lncRNA and circRNA targets in human nasopharyngeal carcinoma. Oncol Lett. 2020;19(4):3123–3136. doi:10.3892/ol.2020.1141232218863
   PubMed Web of Science ®Google Scholar
• Yang B, Jia L, Ren H, et al. LncRNA DLX6-AS1 increases the expression of HIF-1alpha and promotes the malignant phenotypes of nasopharyngeal carcinoma cells via targeting MiR-199a-5p. Mol Genet Genomic Med. 2020;8(1):e1017. doi:10.1002/mgg3.101731782911
   PubMed Web of Science ®Google Scholar
• Chen X, Huang Y, Shi D, et al. LncRNA ZNF667-AS1 promotes ABLIM1 expression by adsorbing micro RNA-1290 to suppress nasopharyngeal carcinoma cell progression. Onco Targets Ther. 2020;13:4397–4409. doi:10.2147/OTT.S24555432606725
   PubMed Web of Science ®Google Scholar
• Li Z, Feng Y, Zhang Z, et al. TMPO-AS1 promotes cell proliferation of thyroid cancer via sponging miR-498 to modulate TMPO. Cancer Cell Int. 2020;20(1):294. doi:10.1186/s12935-020-01334-432669970
   PubMed Web of Science ®Google Scholar
• Mitobe Y, Ikeda K, Sato W, et al. Proliferation-associated long noncoding RNA, TMPO-AS1, is a potential therapeutic target for triple-negative breast cancer. Cancer Sci. 2020;111(7):2440–2450. doi:10.1111/cas.1449832437068
   PubMed Web of Science ®Google Scholar
• Sun Y, Han C. Long non-coding RNA TMPO-AS1 promotes cell migration and invasion by sponging miR-140-5p and inducing SOX4-mediated EMT in gastric cancer. Cancer Manag Res. 2020;12:1261–1268. doi:10.2147/CMAR.S23589832110100
   PubMed Web of Science ®Google Scholar
• Yu X, Lin Q, Liu F, et al. LncRNA TMPO-AS1 facilitates the proliferation and metastasis of NSCLC cells by up-regulating ERBB2 via sponging miR-204-3p. Int J Immunopathol Pharmacol. 2020;34:2058738420958947. doi:10.1177/205873842095894732969763
   PubMed Web of Science ®Google Scholar
• Luo H, Yang L, Liu C, et al. TMPO-AS1/miR-98-5p/EBF1 feedback loop contributes to the progression of bladder cancer. Int J Biochem Cell Biol. 2020;122:105702. doi:10.1016/j.biocel.2020.10570232087328
   PubMed Web of Science ®Google Scholar
• Tian X, Liu Y, Wang Z, Wu S. lncRNA SNHG8 promotes aggressive behaviors of nasopharyngeal carcinoma via regulating miR-656-3p/SATB1 axis. Biomed Pharmacother. 2020;131:110564. doi:10.1016/j.biopha.2020.11056432920509
   PubMed Web of Science ®Google Scholar
• Zhao H, Dong T, Zhou H, et al. miR-320a suppresses colorectal cancer progression by targeting Rac1. Carcinogenesis. 2014;35(4):886–895. doi:10.1093/carcin/bgt37824265291
   PubMed Web of Science ®Google Scholar
• He W, Huang Y, Jiang CC, et al. miR-100 inhibits cell growth and proliferation by targeting HOXA1 in nasopharyngeal carcinoma. Onco Targets Ther. 2020;13:593–602. doi:10.2147/OTT.S22878332021301
   PubMed Web of Science ®Google Scholar
• Shi S, Cao X, Gu M, et al. Upregulated expression of SOX4 is associated with tumor growth and metastasis in nasopharyngeal carcinoma. Dis Markers. 2015;2015:658141. doi:10.1155/2015/65814126578818
   PubMed Web of Science ®Google Scholar
• Peng X, Liu G, Peng H, et al. SOX4 contributes to TGF-beta-induced epithelial-mesenchymal transition and stem cell characteristics of gastric cancer cells. Genes Dis. 2018;5(1):49–61. doi:10.1016/j.gendis.2017.12.00530258935
   PubMed Web of Science ®Google Scholar